Assembly Biosciences Inc

XNAS:ASMB  
29.45
+0.37 (+1.27%)
6:13:09 PM EDT: $29.80 +0.35 (+1.19%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)464.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.46 Million
Adjusted EPS-$0.82
See more estimates
10-Day MA$27.45
50-Day MA$24.84
200-Day MA$16.82
See more pivots

Assembly Biosciences Inc Stock, XNAS:ASMB

Two Tower Place, 7th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 65
http://www.assemblybio.com

Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.